TABLE 2.
Strain | bNAb | Value under indicated transmission conditions |
|||
---|---|---|---|---|---|
Cell free |
Cell to cell |
||||
IC50 | % maximum neutralization | IC50 | % maximum neutralization | ||
NLCIQH0692 | Leu3a | 0.01 | 100 | 0.02 | 100 |
2G12 | 2.24 | 90.5 | 83.0 | 35.9a | |
VRC01 | 0.28 | 93.2 | 12.6 | 51.5a | |
HJ16 | 0.56 | 92.8 | 34.8 | 55.3a | |
2F5 | 0.008 | 91.8 | 2.8 | 74.3 | |
4E10 | 0.1 | 95.8 | 7.4 | 59.2 | |
35O22 | 0.002 | 97.2 | 6.9 | 56.1 | |
PG9 | NAb | NA | NA | NA | |
PGT121 | 0.058 | 89.1 | 0.1 | 69.7 | |
10-1074 | 0.02 | 91.1 | 0.14 | 74 | |
PGT126 | 0.003 | 98.9 | 0.3 | 80 | |
NLCIRHPA | Leu3a | 0.01 | 100 | 0.01 | 100 |
2G12 | NA | NA | NA | NA | |
VRC01 | 1.3 | 80a | 4.6 | 66.7a | |
HJ16 | 0.004 | 96.6 | 0.17 | 62.1 | |
2F5 | 0.13 | 90.1 | 9.5 | 60.4 | |
4E10 | 1.3 | 99.2 | 146 | 55.8a | |
35O22 | NA | NA | NA | NA | |
PG9 | 5.1 | 73.5a | >50 | 38.2a | |
PGT121 | 0.013 | 96.0 | 0.16 | 66.1 | |
10-1074 | 0.021 | 90.3 | >25 | 44.8 | |
PGT126 | 0.013 | 100 | >25 | 42.1 | |
NLCINL4-3 | Leu3a | 0.03 | 96.5 | 0.04 | 96.4 |
2G12 | 0.1 | 99.9 | 3.6 | 95.5 | |
VRC01 | 0.17 | 96.9 | 2.1 | 98.9 | |
HJ16 | 0.02 | 96.6 | 0.9 | 97.2 | |
2F5 | 0.06 | 93.1 | 4.5 | 99 | |
4E10 | 0.3 | 99.4 | 5.9 | 94.5 | |
35O22 | 0.01 | 90.1 | 0.07 | 92.9 | |
PG9 | 0.36 | 81.9a | 2.5 | 72a | |
PGT121 | NA | NA | NA | NA | |
10-1074 | NA | NA | NA | NA | |
PGT126 | NA | NA | NA | NA | |
NLCIJR-FL | Leu3a | 0.04 | 97.7 | 0.1 | 94.7 |
2G12 | 0.3 | 97.8 | 0.7 | 90.9 | |
VRC01 | 0.04 | 96.0 | 0.5 | 94.7 | |
HJ16 | NA | NA | NA | NA | |
2F5 | 0.03 | 99.8 | 1.4 | 90.1 | |
4E10 | 1.0 | 96.1 | 9.2 | 95.6 | |
35O22 | 0.002 | 96.4 | 1.0 | 70.1a | |
PG9 | NA | NA | NA | NA | |
PGT121 | 0.04 | 99.8 | 0.03 | 97.5 | |
10-1074 | 0.01 | 100 | 0.09 | 97.4 | |
PGT126 | 0.1 | 100 | 0.07 | 100 |
The maximum percentage of inhibition detected in these assays was not saturated at the highest concentration tested.
NA, not active, due to low inhibitory activity.